Delivery Order SPE2DB20D2104-SPE2DB25FMMFP

Award Date 3/31/25
Potential Completion Date 4/1/25
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,319.81 delivery order contract is for the supply of JANUVIA 100 MG TABLET 90S, a medication used to treat type 2 diabetes. The contract has a firm fixed price pricing type and a completion date of June 6, 2025. This award is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by...
This federal contract award, with a ceiling value of $37,675.23, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUVIA 100 MG TABLET 1000S, a prescription medication used to treat type 2 diabetes. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award is a delivery order valued at $1,292.51 issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the procurement of JANUVIA 100 MG TABLET 90S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,134.52, is for the supply of JANUVIA 100 MG TABLET 1000S, a medication used to treat type 2 diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of November 4, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,721.63 delivery order contract is for the supply of JANUVIA 100 MG TABLET 1000S, a medication used to treat type 2 diabetes. The contract is a firm-fixed price arrangement with a completion date of May 22, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JANUVIA 50 MG TABLET 90S, a medication used to treat type 2 diabetes. The contract has a firm fixed price of $1,247.94 and a performance period ending on May 22, 2025. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award, valued at $56,925.96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of JANUVIA 100 MG TABLET 90S, a medication used in the treatment of diabetes. The contract has an ultimate completion date of January 9, 2025 and a pricing type of Firm Fixed Price. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award is a delivery order valued at $2,126.07 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUVIA 100 MG TABLET 90S, a prescription medication, with a completion date of June 9, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds...
This federal contract award, valued at $1,737.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order that covers the procurement of JANUVIA 100 MG TABLET 90S, a medication used to treat type 2 diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of July 5, 2022. This contract award is part of a larger Indefinite Delivery...
This federal contract award, valued at $1,091.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The contract is a Firm Fixed Price Delivery Order with a completion date of March 28, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMMFP
    Delivery Order

This federal contract award is a delivery order with a ceiling value of $20,071.77, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JANUVIA 100 MG TABLET 1000S, a medication used to treat type 2 diabetes. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/30/25, 11:03 AM